This study demonstrated that elevated level of PAI-1 is significantly associated with poor prognosis of cervical cancer, especially in the stage III patients treated without brachytherapy, further supporting the critical role of SASP in cervical cancer treatment outcome. Here, SERPINE1 is linked to cervical cancer.